144 related articles for article (PubMed ID: 21419457)
1. Predictive factors for malignant pheochromocytoma: analysis of 136 patients.
Feng F; Zhu Y; Wang X; Wu Y; Zhou W; Jin X; Zhang R; Sun F; Kasoma Z; Shen Z
J Urol; 2011 May; 185(5):1583-90. PubMed ID: 21419457
[TBL] [Abstract][Full Text] [Related]
2. Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma.
Saffar H; Sanii S; Heshmat R; Haghpanah V; Larijani B; Rajabiani A; Azimi S; Tavangar SM
Am J Clin Pathol; 2011 Mar; 135(3):454-60. PubMed ID: 21350102
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
[TBL] [Abstract][Full Text] [Related]
4. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of screening tests for pheochromocytoma.
Hengstmann JH
Cardiology; 1985; 72 Suppl 1():153-6. PubMed ID: 4053123
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
Pacak K; Eisenhofer G; Ahlman H; Bornstein SR; Gimenez-Roqueplo AP; Grossman AB; Kimura N; Mannelli M; McNicol AM; Tischler AS;
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):92-102. PubMed ID: 17237836
[TBL] [Abstract][Full Text] [Related]
7. Stathmin as a marker for malignancy in pheochromocytomas.
Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
[TBL] [Abstract][Full Text] [Related]
8. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas.
Gao B; Meng F; Bian W; Chen J; Zhao H; Ma G; Shi B; Zhang J; Liu Y; Xu Z
Urology; 2006 Aug; 68(2):282-6. PubMed ID: 16904437
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.
Waldmann J; Fendrich V; Holler J; Buchholz M; Heinmöller E; Langer P; Ramaswamy A; Samans B; Walz MK; Rothmund M; Bartsch DK; Slater EP
Endocr Relat Cancer; 2010 Sep; 17(3):743-56. PubMed ID: 20562231
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.
Tavangar SM; Shojaee A; Moradi Tabriz H; Haghpanah V; Larijani B; Heshmat R; Lashkari A; Azimi S
Pathol Res Pract; 2010 May; 206(5):305-9. PubMed ID: 20189725
[TBL] [Abstract][Full Text] [Related]
12. [Role of immunohistochemical study of extracellular matrix components in the estimation of the malignant potential of adrenal pheochromocytomas].
Bezuglova TV; Poliakova GA; Kazantseva IA
Arkh Patol; 2008; 70(6):19-21. PubMed ID: 19227276
[TBL] [Abstract][Full Text] [Related]
13. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients.
Václavík J; Stejskal D; Lacnák B; Lazárová M; Jedelský L; Kadalová L; Janosová M; Frysák Z; Vlcek P
J Hypertens; 2007 Jul; 25(7):1427-31. PubMed ID: 17563565
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
15. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and therapy of pheochromocytoma].
Sato T
Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):523-8. PubMed ID: 1619332
[No Abstract] [Full Text] [Related]
17. Pheochromocytoma: Positive predictive values of mildly elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients.
Hirsch D; Grossman A; Nadler V; Alboim S; Tsvetov G
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1527-1533. PubMed ID: 31486577
[TBL] [Abstract][Full Text] [Related]
18. [Malignant pheochromocytoma: diagnosis and treatment].
Yang D; Li S; Li X; Liu S; Wang H; Han W; Hao J
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):104-5. PubMed ID: 11829794
[TBL] [Abstract][Full Text] [Related]
19. [Apropos of biological diagnosis of pheochromocytoma].
Cier JF; Peyrin L
Nouv Presse Med; 1978 May; 7(21):1863. PubMed ID: 673745
[No Abstract] [Full Text] [Related]
20. Expression and diagnostic relevance of heat shock protein 90 and signal transducer and activator of transcription 3 in malignant pheochromocytoma.
Xu Y; Qi Y; Rui W; Zhu Y; Zhang C; Zhao J; Wei Q; Wu Y; Shen Z; Ning G
J Clin Pathol; 2013 Apr; 66(4):286-90. PubMed ID: 23322822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
